New drug discovery is extremely inefficient. Estimates of the average R&D cost per new drug are less than $1 billion to more ...

On FDA drug approvals and the American diet.

Seattle-based biotech company Athira Pharma is laying off 49 people, or about 70% of its workforce, as part of ...

One witness at Tuesday's hearing, retired RN and patient Judy Aiken of Portland, Maine, testified that the IRA was crucial in ...

A first-of-its-kind analysis conducted as part of an investigation by journalists in eight countries found that some of the ...

Arzeda, a protein design startup that generates new enzymes for industrial, agricultural and other applications, announced a ...

A business journalist who famously ditched her husband and job for disgraced “Pharma Bro” Martin Shkreli defended New York ...

Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

The climate crisis is already impacting nearly every therapeutic area, according to a new report. Pharma marketers are ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

Fierce Pharma’s Andrea Park and Ben Adams talk about major trends from the event that came up in conversations, including the ...